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Abstract
Background: Elevated serum immunoglobulin (Ig) E is a diagnostic marker of immediate-type allergic reactions. We
hypothesize that serum IgE does not necessarily reflect total body IgE because in vivo IgE can be bound to cell surface
receptors such as FceRI and FceRII (CD23). The aim of this study was to analyze the relationships between levels of serum
IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population.
Methodology: Whole blood samples from 48 children (26 boys, 22 girls, mean age 10,365,4 years) were analyzed by flow
cytometry for FceRI, CD23, and cell-bound IgE on dendritic cells (CD11c+MHC class II+), monocytes (CD14+), basophils
(CD123+MHC class II-) and neutrophils (myeloperoxidase+). Total serum IgE was measured by ELISA and converted into z-
units to account for age-dependent normal ranges. Correlations were calculated using Spearman rank correlation test.
Principal Findings: Dendritic cells, monocytes, basophils, and neutrophils expressed the high affinity IgE-receptor FceRI.
Dendritic cells and monocytes also expressed the low affinity receptor CD23. The majority of IgE-receptor positive cells
carried IgE on their surface. Expression of both IgE receptors was tightly correlated with cell-bound IgE. In general, cell-
bound IgE on FceRI+ cells correlated well with serum IgE. However, some patients carried high amounts of cell-bound IgE
despite low total serum IgE levels.
Conclusion/Significance: In pediatric patients, levels of age-adjusted serum IgE, cell-bound IgE, and FceRI correlate. Even in
the absence ofelevatedlevelsofserum IgE, cell-boundIgEcanbedetectedonperipheralbloodcellsina subgroupof patients.
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Introduction
Immunoglobulin (Ig) E and its cell surface receptors, the high
affinity receptor FceRI and the low affinity receptor FceRII
(CD23), are key components of immediate-type allergic reactions
[1]. IgE activates the allergic cascade effectively via the high
affinity receptor, FceRI, on blood- and tissue cells. As a member of
the immunoglobulin receptor superfamily, FceRI consists of a
ligand-binding immunoglobulin domain-containing protein (a-
chain) which binds the Fc-part of IgE and signaling subunits that
regulate cellular activation (b- and c-chains) [2]. Humans express
a tetrameric FceRI (FceRIabc2) on mast cells and basophils and a
trimeric form (FceRIac2) on antigen presenting cells [2,3]. FceRI
expression is regulated by IgE since binding of monomeric IgE to
FceRIa stabilizes the receptor at the cell surface as an IgE-FceRI
complex [4,5,6]. Hence, in vivo, individuals with high serum IgE
levels show enhanced FceRI surface expression on peripheral
blood basophils, monocytes, and dendritic cells [7,8,9].
In the blood, the low affinity IgE receptor CD23 is expressed on
B-cells [1], monocytes [10], and dendritic cells [11,12]. CD23 is a
member of the C-type lectin superfamily. Its IgE binding sites
consist of 3 lectin-type head domains on triple a-helical coiled-coil
stalk domains [1]. The stalk region of CD23 is sensitive to
proteolysis, which results in the release of soluble fragments
[13,14]. No correlation between serum IgE and cell surface CD23
levels has been described [10]. In fact, CD23 is being discussed as
a regulator of IgE synthesis through a complex interplay of co-
ligations of CD23, soluble CD23, IgE, IgE-allergen complexes,
and the complement receptor CD21 on B-cells [1].
Serum IgE is an essential laboratory parameter in the diagnosis
of allergies. Serum IgE levels generally correlate with the severity
of allergic diseases [15,16,17]. However, a subgroup of allergic
patients has serum IgE levels in the normal range [18,19]. We
therefore hypothesized that serum IgE does not necessarily reflect
total body IgE because in vivo IgE can be bound to its cell surface
receptors FceRI and CD23. The aim of this study was to analyze
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12204the relationships between levels of serum IgE, cell-bound IgE, and
IgE-receptors on peripheral blood cells of pediatric patients.
Materials and Methods
Study population
This analysis was performed as a substudy within an ongoing
prospective cohort study on the role of FceRI in the gastrointestinal
tract. Patients scheduled for an elective esophago-gastro-duodeno-
scopy at the Division of Gastroenterology at Children’s Hospital
Boston were randomly invited to participate. Subjects between 1
and 18 years of age were enrolled. Patients’ characteristics such as
age, gender, and race were obtained in a structured interview.
Subjects with a recent (,3 months) use of steroid in any form,
immunomodulatory drugs, mast cell stabilizer, or leukotriene
inhibitor, as well as patients with an established diagnosis of
autoimmune, inflammatory, or immunodeficiency disease and
patients under 1 year of age were excluded from the study. The
studyprotocol was approved bythe InvestigationalReviewBoardat
Children’s Hospital Boston (Harvard Medical School, Boston, MA).
Patients or their legal guardians provided written informed consent.
We obtained peripheralblood samples for serum IgE measurements
and flow cytometry analysis at the time of enrollment.
Total serum IgE
Total serum IgE was determined using a solid-phase ELISA
(DiaMed Eurogen, Turnhout, Belgium) according to the manu-
facturer’s instructions. In brief, plates pre-coated with an anti-IgE
monoclonal antibody were incubated with patient sera and a
second anti-IgE antibody conjugated to horseradish peroxidase.
After washing, levels of bound IgE were determined by incubating
with tetramethylbenzidine (TMB) solution and stopping the
reaction with 2N H2SO4 before reading ODs at 450 nm. Normal
serum IgE levels are given by the manufacturer as ,10 IU/ml for
age 0–3 years, ,25 IU/ml for 3–4 years, ,50 IU/ml for 4–7
years, ,100 IU/ml for 7–14 years, and ,150 IU/mL for adults
older than age 14. IgE levels above the age specific normal range
are referred to as ‘elevated’ IgE from here on.
Flow cytometry analysis of IgE-receptors and IgE on
peripheral blood cells
100 microl of K2EDTA blood were stained following the Becton
Dickinson protocol for direct immunofluorescence staining of
whole blood (http://www.bdbiosciences.ca/canada/downloads/
is_protocols/IF_WB_LW.pdf). The following antibodies were used:
anti-IgE FITC (Invitrogen), anti-FceRIa APC (mAb CRA1,
eBioscience, San Diego, CA), anti-CD23 APC, anti-myeloperoxi-
dase (MPO)-PE for neutrophils, anti-CD14 PerCP-Cy5.5 for
monocytes, anti-CD11c V450 and anti-MHC class II-PerCP (all
BD Biosciences)fordendriticcells.Basophils wereidentifiedbyanti-
CD123-PE (BD) and negativity for MHC class II.
Blood was incubated with antibodies for 20 minutes at room
temperature to stain for cell surface IgE, IgE receptors and linage-
specific surface markers. Red blood cells were lysed with 16BD
FACS
TM Lysing Solution (BD Biosciences, San Jose, CA). After
surface staining, neutrophils were identified by intracellular
expression of MPO using FIX&PERMH (Invitrogen, Carlsbad,
CA) according to the manufacturer’s guidelines. Cells were washed
and resuspended in PBS for flow cytometry analysis. Correspond-
ing isotype controls were performed for each staining.
Data were acquired with a DakoCytomation MoFlo Legacy
(Dako North America Inc., Capinteria, CA) and analyzed with
Summit for Windows Version 4.3 (Dako North America Inc.).
Typically, 20,000 events within the granulocytes/monocytes gate
in the forward/side scatter plot were acquired. FceRI and CD23
levels were determined as percent (%) positive cells among cell
type after subtraction of the individual isotype control background.
Cell-bound IgE levels were recorded as the percentage of cells that
were double positive for IgE and FceR1 or IgE and CD23 after
subtraction of background.
Statistical analysis
Data were analysed with SPSS for Windows (version 16.0, SPSS
Inc., Chicago, IL). Chi-square test was used for nominal variables.
Continuous variables were compared by Student’s T-test or Mann-
Whitney-U where called for. Correlations were calculated using
Spearman’s rank correlation test since datasets were not normally
distributed. Spearman’s rank correlation coefficients are displayed
as ‘rho’. To account for age-dependent normal ranges, total IgE
levels were converted into z-units as published by Kjellman et al.
[20]. A p-value of ,0.05 was considered significant.
Results
A total of 48 pediatric patients were included in the study
between October 3, 2008 and July 17, 2009 (26 boys, 22 girls,
mean age 10.365.4years). The characteristics of the study
population are given in Table 1.
Surface FceRI on peripheral blood dendritic cells and
monocytes correlates with serum IgE levels in children
with elevated IgE
All patients expressed FceRI on their dendritic cells (DCs).
FceRI-expression ranged between 2.54 and 26.43% FceRI+ DCs
(Table 2). The majority of patients also expressed FceRI on
monocytes (44/48), with a range of expression between 0.19 and
17%, basophils (45/48, 0.53–60.17% positive cells), and neutro-
phils (35/47, 0.1–4.36% positive cells). Among all children, DC
and monocyte FceRI expression slightly increased with age
(Figure 1, rho=0.305, p=0.039 for DCs, rho=0.329, p=0.026
for monocytes).
Patients with elevated serum IgE (n=14) showed a significant
correlation between age-normalized serum IgE z-units and FceRI
on dendritic cells (rho=0.552, p=0.041, Figure 2A). A tendency








Subjects, n (%) 48 34 (70,8) 14 (29,2)
Age, mean6SD 10.365.4 11.664.5 7.366.3 0.033
{
Gender
Male, n (%) 26 (54.2) 19 (55.8) 7 (50)
Female, n (%) 22 (45.8) 15 (44.1) 7 (50) 0.71
{
Race (n)
Caucasian 39 28 11
Asian 1 1 -
African American 1 - 1
Caucasian/Asian 2 1 1
Caucasian/Native American 2 1 -
N/A 3 2 1
{Student’s T-test,
{Chi-Square test. SD = standard deviation, N/A = not specified.
doi:10.1371/journal.pone.0012204.t001
Cell-Bound IgE on Blood Cells
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was observed (rho=0.514, p=0.06, Figure 2A). FceRI on
basophils and neutrophils showed no association with serum IgE
(Figure 2A), nor did FceRI expression levels in children with
normal IgE (n=34, Figure 2B).
Numbers of CD23+ cells were lower than FceRI+ cells (Table 2).
DCs from 20 and monocytes from 11 out of 48 patients expressed
this receptor (0.03%–4.25% CD23+ DCs and 0.29–6.96% CD23+
monocytes in individual subjects). One patient expressed CD23 on
basophils and another one on neutrophils. Surface CD23-levels
did not correlate with serum IgE (IU/l or z-units) on any of the cell
types analyzed in this study (data not shown).
Cell surface-bound IgE correlates with serum IgE and
IgE-receptor expression
FceRI+ DCs from 45 of 48, FceRI+ monocytes and basophils
from 41 of 48, as well as FceRI+ neutrophils from 28 of 47 patients
stained positive for IgE (Table 2). Percentages of cell surface-IgE
positive cells ranged from 0.02 to 17.5% in DCs, 0.1 to 9.66% in
monocytes, 0.01 to 61.34% in basophils, and 0.13 to 1.86% in
neutrophils. In agreement with our analysis on CD23 expression,
we found lower numbers of IgE-loaded CD23+ cells (DCs 17/48,
0.02–4.18% IgE-loaded cells; monocytes 12/48, 0.01–3.92% IgE-
loaded cells; basophils 1/48, 1.8% IgE-loaded cells, and
neutrophils 1/47, 0.17% IgE-loaded cells).
On FceRI+ DCs, monocytes, and neutrophils, a positive
correlation between cell-bound IgE and absolute total serum IgE
was detected (IU/l, Table 3A). Accordingly, age-normalized IgE
levels in z-units correlated positively with IgE on the surface of
FceRI+ DCs and monocytes (rho=0.415, p=0.003 and
rho=0.354, p=0.013, respectively, Table 3A). Cell-bound IgE
on CD23+ cells did not correlate with serum IgE.
Cell-bound IgE was linked to IgE-receptor expression. FceRI-
expression significantly correlated with cell-bound IgE in FceRI+
DC’s, monocytes, and basophils. CD23-expression correlated with
cell-surface IgE in CD23+ DC and monocytes (Table 3B).
IgE-positive peripheral blood cells are detected in the
absence of elevated serum IgE levels
We next analyzed whether elevated serum IgE is reflected by
high numbers of cell-bound IgE. We found that numbers of IgE-
positive cells did not significantly differ between children with
elevated and normal serum IgE (Mann-Whitney-U test, Figure 3).
We found, however, a considerable number of patients with high
levels of cell-bound IgE on their monocytes, basophils, and
neutrophils despite normal serum IgE. These data provide
evidence that the body IgE-pool consists of a soluble serum IgE
fraction and a circulating cell-bound fraction.
Discussion
In this work we have correlated levels of cell-bound IgE on
peripheral blood cells of pediatric patients with total serum IgE
and IgE-receptors. Analyzing expression of the high affinity IgE
receptor FceRI, we observed a slight increase of FceRI expression
on DC and monocytes with age, which is in line with previous
findings by Wada et al. [21]. We found that the majority of
FceRI+ dendritic cells, monocytes, basophils and neutrophils carry
IgE on their surface. Serum IgE levels correlated positively with
levels of cell-bound IgE. Serum IgE positively correlated with
FceRI levels on dendritic cells and to a lesser extent on monocytes
in children with elevated IgE. We also found a population of
patients that carry high amounts of cell-bound IgE in the absence
of elevated levels of serum IgE.
An association between cell surface density of FceRI and serum
IgE levels has been described for adult atopic patients
[7,8,9,22,23]. In mixed-age pediatric populations, comparing
IgE values is complicated by age-related normal ranges for IgE
and such a relation has not been described yet. In healthy
Figure 1. FceRI expression increases with age in dendritic cells and monocytes. Data points represent percent (%) positive cells among cell
type after subtraction of isotype control background in individual children.
doi:10.1371/journal.pone.0012204.g001
Table 2. Peripheral blood dendritic cells, monocytes,
basophils, and neutrophils express FceRI, CD23 and




DC (CD11c+)F c eRI 48/48 8.02 (2.54–26.43)
CD23 20/48 1.04 (0.03–4.25)
IgE on FceRI + 45/48 2.63 (0.02–17.5)
IgE on CD23+ 17/48 0.72 (0.02–4.18)
Monocytes (CD14+)F c eRI 44/48 2.54 (0.19–17.0)
CD23 11/48 0.8 (0.29–6.96)
IgE on FceRI+ 41/48 1.18 (0.1–9.66)
IgE on CD23+ 11/48 0.27 (0.01–3.92)
Basophils
(CD123+MHCII-)
FceRI 45/48 7.22 (0.53–60.17)
CD23 1/48 0.81
IgE on FceRI+ 41/48 3.54 (0.01–61.34)
IgE on CD23+ 1/48 1.8
Neutrophils (MPO+)F c eRI 35/47 0.31 (0.01–4.36)
CD23 1/47 2.65
IgE on FceRI+ 28/47 0.13 (0.01–1.86)
IgE on CD23+ 1/47 0.17
Number of positive cells, median and range of % positive cells among the
respective population is shown. If n=1, the % positive cells in this patient is
displayed.
doi:10.1371/journal.pone.0012204.t002
Cell-Bound IgE on Blood Cells
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hence absolute IgE levels have a different pathophysiological
relevance in different age groups. Comparing absolute values
would not account for these age-dependent cut-off levels. This
problem is commonly solved by converting absolute IgE levels to
age-normalized z-values as published by Kjellman et al. [20]. Using
age-related z-units, we here demonstrated that high levels of serum
IgE are associated with high surface expression of FceRI in children
as well. Another novel finding of this study is the close positive
correlation between cell-bound IgE and FceRI on DC, monocytes,
and basophils in children. Our findings support previous data
showing that serum IgE is associated with an upregulation of FceRI
as a consequence of IgE binding and stabilization of the receptor
complex on the cell surface [4,5,6]. In line with previous reports, we
showed that FceRI on neutrophils in our study population was
neither regulated by serum- nor cell-bound IgE. This adds to the
notion that IgE does not affect FceRI expression on neutrophils
[24,25].
CD23 expression was not associated with serum IgE, which is
consistent with a previous report [10]. Hence, serum IgE does not
seem to be involved in regulation of CD23 expression. CD23
expression was, however, correlated with cell-bound IgE. Receptor
stabilization by IgE has not been described for CD23 yet. It has
however been described that IgE-bound CD23 is shedded from
the cell surface and that a soluble form of CD23 is found in
patients with high levels of serum IgE [1]. As flow cytometry only
allows for the identification of IgE and IgE–receptor double-
positive cells, we cannot assess if a receptor is in fact loaded with
IgE. We thus cannot rule out that CD23+ cells actually bind IgE
via FceRI. To our knowledge, it has also not been studied whether
FceRI and CD23 expression are interrelated. One could speculate
that IgE-mediated surface stabilization of FceRI synergistically
Figure 2. Serum IgE enhances FceRI on dendritic cells and monocytes from patients with elevated IgE. A. Cell surface levels of FceRI on
dendritic cells and monocytes correlate with serum IgE in children with elevated IgE. B. No correlation was found in patients with normal serum IgE.
Data points represent percent (%) positive cells among cell type after subtraction of isotype control background in individual patients.
doi:10.1371/journal.pone.0012204.g002
Table 3. Cell surface-bound IgE correlates with serum IgE and IgE-receptor expression.
A Cell-bound IgE on FceRI+ cells
Cell-bound IgE




units) DC Monocytes Basophils Neutrophils DC Monocytes DC Monocytes Basophils Neutrophils
IgE
(IU/ml)
1.0 0.747* 0.653* 0.514* 20.003 0.429* 0.000 20.097 FceRI+
cells
0.442* 0.477* 0.662* 0.286
IgE (z-
units)
0.747* 1.0 0.416* 0.349* 0.161 0.246 20.44 20.04 CD23+
cells
0.500* 0.702*
A. Surface-bound IgE in FceRI+ DC, monocytes, and neutrophils correlates with serum IgE. B.F c eRI-expression correlates with surface-bound IgE in FceR+ DC, monocytes,
and basophils, CD23-expression correlates with surface-bound IgE in CD23+ DC and monocytes (Spearman rank correlation, respectively).
*p,0.05.
doi:10.1371/journal.pone.0012204.t003
Cell-Bound IgE on Blood Cells
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and IgE-allergen complexes.
In our study, cell-bound IgE on FceRI+ cells generally
correlated well with elevated serum IgE. In a subgroup of patients
though, monocytes, basophils, and neutrophils were loaded with
IgE despite normal or low serum IgE levels. Allergic diseases in the
absence of elevated serum IgE levels have been described in the
literature [18,19]. We conclude from our data that free serum IgE
does not necessarily reflect the body IgE pool. In support of this
idea, Liang et al. recently showed IgE-positive cells in peripheral
blood. As in our pediatric population, Liang et al. found in healthy
and allergic adults that, cell surface-bound IgE and serum IgE
correlate well. In line with our findings, this study also observed a
discordance in serum IgE and cell-bound IgE in some individuals
[26]. We thus propose that the body IgE-pool is composed of a
soluble serum IgE fraction and a circulating cell-bound fraction.
IgE bound to the high affinity IgE-receptor, FceRI, on immune
effector cells can travel to sites of allergen contact like mucous
membranes and cause allergic symptoms. In patients with normal
serum IgE as defined by conventional IgE-assays, cell surface
bound IgE could sensitize immune cells and trigger allergic
reactions. Unfortunately, no data on physician-diagnosed allergies
was available for our study population. Due to this limitation of
our study, we can only speculate about the role of cell-bound IgE
in allergic conditions at this point. Further prospective studies are
currently being performed to address this important topic.
Comparable to the increase in FceRI expression by elevated
serum IgE, monoclonal anti-IgE antibodies, such as Omalizumab,
decrease serum IgE and FceRI-surface expression on dendritic
cells, monocytes, and basophils [27,28,29,30]. Lower levels of
surface FceRI consequently render immune cells less sensitive to
allergen stimuli [31]. Determining cell-bound IgE could be a
valuable additional parameter in monitoring IgE-sensitized
immune cells during anti-IgE therapy. Overall, measuring cell-
bound IgE could be particularly useful in estimating the allergy
risk of children with normal serum IgE levels.
In summary, we find that in pediatric patients, levels of age-
adjusted serum IgE and IgE-receptors correlate. The majority of
FceRI+ cells also carry IgE on their surface. Cell-bound IgE on
FceRI+ cells correlated well with high levels of serum IgE. We also
identified pediatric patients who carried IgE at the surface of
peripheral blood cells while serum IgE levels were normal. Further
prospective cohort studies are needed for a detailed analysis of the
correlation between cell-bound IgE with clinical symptoms of
allergy and therapeutic responses. We propose here that
measuring cell-bound IgE could be a valuable additional
laboratory parameter in the assessment of IgE-mediated allergies.
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